IGFBP3 and breast carcinoma: In summary, results from this large collaborative study support previous evidence that specific genetic variants in IGF1 and IGFBP3 genes significantly influence circulating levels of IGF-I and IGFBP-3, respectively, but have no measurable effect on breast cancer risk.